QQ客服 官方微博 反馈留言

	Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients
	Zhu, Gui-Qi; Yang, Yi; Chen, Er-Bao; Wang, Biao; Xiao, Kun; Shi, Shi-Ming; Zhou, Zheng-Jun; Zhou, Shao-Lai; Wang, Zheng; Shi, Ying-Hong
刊名	JOURNAL OF TRANSLATIONAL MEDICINE
	2019
卷号	17
关键词	Hepatocellular carcinoma Liver resection Molecular classification Microarray analysis
ISSN号	1479-5876
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3596048
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Zhu, Gui-Qi,Yang, Yi,Chen, Er-Bao,et al. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients[J]. JOURNAL OF TRANSLATIONAL MEDICINE,2019,17.
APA	Zhu, Gui-Qi.,Yang, Yi.,Chen, Er-Bao.,Wang, Biao.,Xiao, Kun.,...&Dai, Zhi.(2019).Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.JOURNAL OF TRANSLATIONAL MEDICINE,17.
MLA	Zhu, Gui-Qi,et al."Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients".JOURNAL OF TRANSLATIONAL MEDICINE 17(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。